-
Add to Cart The item has been addedAb176608-10mgTTX-030 (anti-ENTPD1) is a fully human monoclonal antibody directed targeting the cell surface receptor CD39. It specifically binds to the CD39 antigen and inhibits both the conversion of adenosine triphosphate (ATP) to adenosine monophosphate (AMP) -
Add to Cart The item has been addedAb176608-1mgTTX-030 (anti-ENTPD1) is a fully human monoclonal antibody directed targeting the cell surface receptor CD39. It specifically binds to the CD39 antigen and inhibits both the conversion of adenosine triphosphate (ATP) to adenosine monophosphate (AMP) -
Add to Cart The item has been addedAb176608-5mgTTX-030 (anti-ENTPD1) is a fully human monoclonal antibody directed targeting the cell surface receptor CD39. It specifically binds to the CD39 antigen and inhibits both the conversion of adenosine triphosphate (ATP) to adenosine monophosphate (AMP) -
Add to Cart The item has been addedAb176222-100μgTusamitamab (anti-CEACAM5) is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab (anti-CEACAM5) can be used to synthesize Tusamitamab ravtansine, which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab -
Add to Cart The item has been addedAb176563-100μgVopratelimab (anti-ICOS) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab (anti-ICOS) retains species cross-reactivity with affinities of 0.93 nM -
Add to Cart The item has been addedAb176563-10mgVopratelimab (anti-ICOS) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab (anti-ICOS) retains species cross-reactivity with affinities of 0.93 nM -
Add to Cart The item has been addedAb176563-1mgVopratelimab (anti-ICOS) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab (anti-ICOS) retains species cross-reactivity with affinities of 0.93 nM -
Add to Cart The item has been addedAb176563-5mgVopratelimab (anti-ICOS) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that pecifically binds to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab (anti-ICOS) retains species cross-reactivity with affinities of 0.93 nM -
Add to Cart The item has been addedAb176075-100μgVorsetuzumab (anti-CD70) is a human anti-CD70 antibody. Vorsetuzumab (anti-CD70) enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.Purity>95% (SDS-PAGE&SEC)Endotoxin -
Add to Cart The item has been addedAb176075-10mgVorsetuzumab (anti-CD70) is a human anti-CD70 antibody. Vorsetuzumab (anti-CD70) enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.Purity>95% (SDS-PAGE&SEC)Endotoxin -
Add to Cart The item has been addedAb176075-1mgVorsetuzumab (anti-CD70) is a human anti-CD70 antibody. Vorsetuzumab (anti-CD70) enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.Purity>95% (SDS-PAGE&SEC)Endotoxin -
Add to Cart The item has been addedAb176075-5mgVorsetuzumab (anti-CD70) is a human anti-CD70 antibody. Vorsetuzumab (anti-CD70) enhances macrophage-related phagocytosis of renal carcinoma cells, shows inhibitory efficacy against Burkitt’s lymphoma.Purity>95% (SDS-PAGE&SEC)Endotoxin
